A spirocyclic BODIPY photosensitizer with pH-triggered triplet-state activation for tumor-selective photodynamic therapy
Abstract
Conventional PDT photosensitizers generally suffer from inherent poor tumor selectivity. We herein develop a novel spirocyclic BODIPY-based photosensitizer (BDP-I) to exploit the weakly acidic tumor microenvironment for targeted selective activation. It enables efficient pH-triggered triplet-state ROS restoration and prominent tumor-selective phototoxicity, providing a promising molecular scaffold for precise tumor-acidity-targeted PDT.
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Photodynamic Therapy Research Studies
Luminescence and Fluorescent Materials
Publication details
- Journal / source
- Chemical Communications
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 62
- Issue
- 46
- Pages
- 11687–11691
- Publication date
- 1 January 2026
- Language
- EN